Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
CYP2D6 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Gene Name: | cytochrome P450, family 2, subfamily D, polypeptide 6 |
Family/Subfamily: | Cytochrome P450 , not assigned-Cytochrome P450 |
Synonyms: | CYP2D6, CPD6, CYPIID6, Cytochrome P450 2D6, CYP2D, CYP2D8P2, Cytochrome p450 iid6, CYP2D7P2, CYP2DL1, Cytochrome P450-DB1, Debrisoquine 4-hydroxylase, p450C2D, p450-DB1, p450DB1, CYP2D7AP, CYP2D7BP |
Target Sequences: | NM_000106 NP_000097.3 P10635 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.